ofloxacin has been researched along with hydroxychloroquine in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 3 (42.86) | 29.6817 |
2010's | 1 (14.29) | 24.3611 |
2020's | 2 (28.57) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Arditi-Djiane, J; Brouqui, P; Houpikian, P; Raoult, D; Riss, JM; Tissot Dupont, H | 1 |
Brown, N; Healy, B; Llewelyn, M; Lloyd, G; Westmoreland, D | 1 |
Cheour, M; Drissa, H; Drissa, MA; Fradi, I | 1 |
Clark, S; Clees, WI; Elkin, KR; Elliott, HA; Hayden, KR; Jones, M; Mashtare, ML; Preisendanz, HE; Read, AF; Richard, TL; Shreve, MJ; Silverman, J; Veith, TL; Watson, JE | 1 |
Eid, M; El-Sayed, A; Elmansi, HM; Shalan, S | 1 |
1 review(s) available for ofloxacin and hydroxychloroquine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
6 other study(ies) available for ofloxacin and hydroxychloroquine
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Treatment of Q fever endocarditis: comparison of 2 regimens containing doxycycline and ofloxacin or hydroxychloroquine.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Doxycycline; Drug Therapy, Combination; Endocarditis, Bacterial; Female; Humans; Hydroxychloroquine; Male; Middle Aged; Ofloxacin; Q Fever; Survival Analysis; Treatment Outcome | 1999 |
The value of follow-up after acute Q fever infection.
Topics: Anti-Bacterial Agents; Antibodies, Bacterial; Chronic Disease; Complement Fixation Tests; Coxiella burnetii; Delivery of Health Care; Doxycycline; Echocardiography, Transesophageal; Endocarditis, Bacterial; Female; Fluorescent Antibody Technique; Humans; Hydroxychloroquine; Middle Aged; Ofloxacin; Q Fever | 2006 |
[Q fever endocarditis: a case report].
Topics: Adult; Anti-Bacterial Agents; Aortic Valve; Aortic Valve Stenosis; Doxycycline; Drug Therapy, Combination; Echocardiography, Transesophageal; Endocarditis, Bacterial; Enzyme Inhibitors; Female; Follow-Up Studies; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; Humans; Hydroxychloroquine; Mitral Valve; Mitral Valve Insufficiency; Mitral Valve Stenosis; Ofloxacin; Q Fever; Radiography, Thoracic; Time Factors; Treatment Outcome | 2006 |
Impacts of the COVID-19 pandemic on pharmaceuticals in wastewater treated for beneficial reuse: Two case studies in central Pennsylvania.
Topics: Acetaminophen; Ampicillin; Animals; Anti-Bacterial Agents; COVID-19; Dexamethasone; Doxycycline; Environmental Monitoring; Humans; Hydroxychloroquine; Naproxen; Ofloxacin; Pandemics; Pennsylvania; Pharmaceutical Preparations; Soil; Sulfamethoxazole; Trimethoprim; Waste Disposal, Fluid; Wastewater; Wastewater-Based Epidemiological Monitoring; Water Pollutants, Chemical | 2022 |
Validated spectrofluorimetric assay of two co-administered drug mixtures containing hydroxychloroquine with either moxifloxacin or ofloxacin as a drug regimen for hospital-acquired pneumonia in patients with COVID-19.
Topics: Anti-Bacterial Agents; COVID-19; COVID-19 Drug Treatment; Hospitals; Humans; Hydroxychloroquine; Moxifloxacin; Ofloxacin; Pandemics; Spectrometry, Fluorescence | 2023 |